From our findings, the activation of the JAK/STAT and MAPK/ERK1,2 signalling pathways did not appear to have significantly altered the production of mROS in HSVSMCs from non-diabetic and T2DM patients. The gene discussed is SOAT1; the disease is type 2 diabetes mellitus.